Preparation of canine relaxin recombinant protein and preparation of monoclonal antibodies thereof
A technology of recombinant protein and relaxin, applied in the direction of relaxin, anti-hormone immunoglobulin, recombinant DNA technology, etc., can solve the problems of hindering the preparation of monoclonal antibodies, poor specificity of monoclonal antibodies, low expression level, etc., to achieve guaranteed detection The effect of broad spectrum, improved detection sensitivity, and improved expression level
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Example 1: Selection of dominant antigenic epitopes of canine relaxin protein
[0022] Taking canine relaxin protein as the target antigen, using the biological software DNAssist2.0 to analyze the hydrophilicity and antigenicity of its antigenic epitope sequence, select A dominant antigenic epitope (SEQ ID No: 2) and B dominant antigenic epitope (SEQ ID No: 2) ID No: 3). At the same time, the sequence comparison results showed that the selected A and B two dominant antigenic epitope sequences had a broad spectrum and were common epitopes of all canine relaxin proteins; and the A and B epitopes had no obvious homology with other protein sequences, Only present in the canine relaxin protein sequence.
Embodiment 2
[0023] Example 2: Concatenation of canine relaxin dominant epitopes
[0024] In order to enhance the activation effect of the selected epitope on the immune system of mice and shorten the preparation time of monoclonal antibodies, the two dominant epitope sequences of canine relaxin nucleoprotein A and B were respectively linked by flexible fragments (four consecutive glycines) Repeat again to obtain the amino acid sequence of the recombinant protein, the specific sequence of which is shown in SEQ ID No: 1 in the sequence table.
Embodiment 3
[0025] Example 3: Optimizing the Nucleotide Sequence Encoding Canine Relaxin Recombinant Protein
[0026] On the premise that the amino acid sequence of canine relaxin recombinant protein remains unchanged, in order to increase the expression of canine relaxin recombinant protein in Escherichia coli, the amino acid sequence encoding canine relaxin recombinant protein was converted into the corresponding nuclear Nucleotide sequence, the specific sequence is shown in the sequence table SEQ ID No: 4, and after adding the nucleotide sequences corresponding to the restriction sites BamHI and EcoRI in the upstream and downstream of it, it was synthesized by Hangzhou Xianzhi Biotechnology Co., Ltd. The synthesized target gene was connected to the pMD20-T vector (Bao Bioengineering Dalian Co., Ltd.).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


